Location History:
- Hayward, CA (US) (1987)
- Castro Valley, CA (US) (2019 - 2020)
- Somerset, NJ (US) (2006 - 2023)
Company Filing History:
3 out of 6 
2 out of 2 
1 out of 8 
Years Active: 1987-2023
Title: Celebrating the Innovations of Kevin Halloran
Introduction
Kevin Halloran, an innovative inventor based in Somerset, NJ, has made significant contributions to the pharmaceutical industry with his groundbreaking inventions. With a portfolio of seven patents, Halloran's work primarily focuses on enhancing the bioavailability and solubility of critical pharmaceutical ingredients, addressing important health challenges.
Latest Patents
Among his latest patents is a remarkable innovation titled "Solid Dispersions." This invention pertains to an ospemifene solid dispersion that enhances solubility and bioavailability. The solid dispersion comprises an active pharmaceutical ingredient, ospemifene, combined with various hydrophilic carriers such as copovidone, hypromellose acetate succinate, and a range of other compounds. This composition has potential applications in treating menopause-related symptoms like vaginal dryness or sexual dysfunction, as well as osteoporosis.
Another significant patent from Halloran involves "Polymorphs of Azabicyclohexane." This innovation presents polymorphic crystalline forms of acid addition salts of (+)-1-(3, 4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, categorized as polymorph form A, form B, and form C. Notably, polymorph form A demonstrates superior thermodynamic stability compared to its counterparts, which is essential for developing effective pharmaceutical compositions.
Career Highlights
Kevin Halloran's career has been marked by his tenure at notable companies such as Euthymics Bioscience, Inc. and Aton Pharma, Inc. His experience at these organizations has undoubtedly contributed to his expertise in pharmaceutical research and development, enhancing his innovative capabilities in creating effective drug formulations.
Collaborations
Throughout his career, Halloran has collaborated with talented professionals like Eric J Hagen and Zhengming Chen. These collaborations have likely fostered a rich environment for knowledge-sharing and innovation, driving advancements in their projects.
Conclusion
Kevin Halloran stands out as a significant figure in the realm of pharmaceutical innovations. His dedication to advancing drug formulations and addressing health issues through his patents reveals his commitment to improving patient outcomes. As his work continues to evolve, the impacts of his inventions will undoubtedly resonate within the industry for years to come.